» Articles » PMID: 31179300

Classification and Differential Diagnosis of Wilson's Disease

Overview
Journal Ann Transl Med
Date 2019 Jun 11
PMID 31179300
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease is characterized by hepatic and extrapyramidal movement disorders (EPS) with variable manifestation primarily between age 5 and 45. This variability often makes an early diagnosis difficult. A classification defines different clinical variants of Wilson's disease, which enables classifying the current clinical findings and making an early tentative diagnosis. Until the unequivocal proof or an autosomal recessive disorder of the hepatic copper transporter ATP7B has been ruled out, differential diagnoses have to be examined. Laboratory-chemical parameters of copper metabolism can both be deviations from the norm not related to the disease as well as other copper metabolism disorders besides Wilson's disease. In addition to known diseases such as Menkes disease, occipital horn syndrome (OHS), Indian childhood cirrhosis (ICC) and ceruloplasmin deficiency, recently discovered disorders are taken into account. These include MEDNIK syndrome, Huppke-Brendel syndrome and CCS chaperone deficiency. Another main focus is on differential diagnoses of childhood icterus correlated with age and anaemia as well as disorders of the extrapyramidal motor system. The Kayser-Fleischer ring (KFR) is qualified as classical ophthalmologic manifestation. The recently described manganese storage disease presents another rare metabolic disorder with symptoms similar to Wilson's disease. As this overview shows, Wilson's disease fits into a broad spectrum of internal and neurological disease patterns with icterus, anaemia and EPS.

Citing Articles

Unmasking Wilson Disease: A Rare Paediatric Case of Haemolysis and Hepatic Dysfunction Without Neurological Features.

Al Zohbi R, Awaida I, Farhat S, Ghandour F Cureus. 2025; 17(1):e77726.

PMID: 39974244 PMC: 11836103. DOI: 10.7759/cureus.77726.


Spectrum and classification of variants with clinical correlation in children with Wilson disease.

Al-Obaidi R, Al-Musawi B Saudi Med J. 2025; 46(2):131-142.

PMID: 39933775 PMC: 11822923. DOI: 10.15537/smj.2025.46.2.20240997.


Clinical, biochemical and molecular characterization of Wilson's disease in Moroccan patients.

Lafhal K, Sabir E, Hakmaoui A, Hammoud M, Aimrane A, Najeh S Mol Genet Metab Rep. 2023; 36:100984.

PMID: 37323222 PMC: 10267639. DOI: 10.1016/j.ymgmr.2023.100984.


Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases.

Lee V, Janisse S, Heffern M Chem Soc Rev. 2023; 52(11):3927-3945.

PMID: 37203389 PMC: 10281457. DOI: 10.1039/d3cs00167a.


Chronic Corticosterone Exposure Suppresses Copper Transport through GR-Mediated Intestinal CTR1 Pathway in Mice.

Guo S, Chen Z, Dong Y, Ni Y, Zhao R, Ma W Biology (Basel). 2023; 12(2).

PMID: 36829476 PMC: 9953443. DOI: 10.3390/biology12020197.


References
1.
DiDonato M, Sarkar B . Copper transport and its alterations in Menkes and Wilson diseases. Biochim Biophys Acta. 1997; 1360(1):3-16. DOI: 10.1016/s0925-4439(96)00064-6. View

2.
Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G . Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease. Eur J Gastroenterol Hepatol. 2007; 19(2):105-11. DOI: 10.1097/01.meg.0000223904.70492.0b. View

3.
Ogimoto M, Anzai K, Takenoshita H, Kogawa K, Akehi Y, Yoshida R . Criteria for early identification of aceruloplasminemia. Intern Med. 2011; 50(13):1415-8. DOI: 10.2169/internalmedicine.50.5108. View

4.
Bahi-Buisson N, Kaminska A, Nabbout R, Barnerias C, Desguerre I, de Lonlay P . Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia. 2006; 47(2):380-6. DOI: 10.1111/j.1528-1167.2006.00432.x. View

5.
Tao T, Liu F, Klomp L, Wijmenga C, Gitlin J . The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem. 2003; 278(43):41593-6. DOI: 10.1074/jbc.C300391200. View